Clinical Trial Update: Allogeneic SCT of CordIn™, in Patients With Hemoglobinopathies [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for Allogeneic cord blood stem cell therapy CordIn in sickle cell disease and thalassemia; study status terminated with posted r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Thalassemia

Drugs mentioned

• CordIn

Snippet

Sponsor: Gamida Cell ltd | Conditions: Sickle Cell Disease, Thalassemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2019-06-26